Emerging evidence suggests that cancer cells may utilize LAP to engulf and process neutrophils, and inhibiting this process has been shown to reduce tumor necrosis and improve survival in a glioblastoma mouse model [118]. This evidence concerns the gene TGFB1 and glioblastoma.